These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37512579)

  • 21. Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review.
    Perazzoli G; García-Valdeavero OM; Peña M; Prados J; Melguizo C; Jiménez-Luna C
    Metabolites; 2023 Jul; 13(7):. PubMed ID: 37512579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics.
    Martín-Blázquez A; Jiménez-Luna C; Díaz C; Martínez-Galán J; Prados J; Vicente F; Melguizo C; Genilloud O; Pérez Del Palacio J; Caba O
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32325731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma.
    Sahni S; Pandya AR; Hadden WJ; Nahm CB; Maloney S; Cook V; Toft JA; Wilkinson-White L; Gill AJ; Samra JS; Dona A; Mittal A
    Int J Cancer; 2021 Mar; 148(6):1508-1518. PubMed ID: 33128797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma.
    Cao Y; Zhao R; Guo K; Ren S; Zhang Y; Lu Z; Tian L; Li T; Chen X; Wang Z
    Front Oncol; 2021; 11():744667. PubMed ID: 35127469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer.
    Muranaka H; Hendifar A; Osipov A; Moshayedi N; Placencio-Hickok V; Tatonetti N; Stotland A; Parker S; Van Eyk J; Pandol SJ; Bhowmick NA; Gong J
    Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37296982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesis.
    Apiz Saab JJ; Dzierozynski LN; Jonker PB; AminiTabrizi R; Shah H; Menjivar RE; Scott AJ; Nwosu ZC; Zhu Z; Chen RN; Oh M; Sheehan C; Wahl DR; Pasca di Magliano M; Lyssiotis CA; Macleod KF; Weber CR; Muir A
    Elife; 2023 May; 12():. PubMed ID: 37254839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cells in pancreatic cancer stroma: Tryptophan metabolism plays an important role in immunoregulation.
    Yang T; Li QQ; Liu YM; Yang B
    World J Gastroenterol; 2023 May; 29(17):2701-2703. PubMed ID: 37213408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification.
    Li F; He C; Yao H; Zhao Y; Ye X; Zhou S; Zou J; Li Y; Li J; Chen S; Han F; Huang K; Lian G; Chen S
    Pharmacol Res; 2023 Jan; 187():106555. PubMed ID: 36403721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study.
    Zhao R; Ren S; Li C; Guo K; Lu Z; Tian L; He J; Zhang K; Cao Y; Liu S; Li D; Wang Z
    Cancer Med; 2023 Feb; 12(4):5158-5171. PubMed ID: 36161527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment.
    Yamamoto K; Iwadate D; Kato H; Nakai Y; Tateishi K; Fujishiro M
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance.
    Vasseur S; Guillaumond F
    Oncogenesis; 2022 Aug; 11(1):46. PubMed ID: 35945203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis.
    Mahajan UM; Oehrle B; Sirtl S; Alnatsha A; Goni E; Regel I; Beyer G; Vornhülz M; Vielhauer J; Chromik A; Bahra M; Klein F; Uhl W; Fahlbusch T; Distler M; Weitz J; Grützmann R; Pilarsky C; Weiss FU; Adam MG; Neoptolemos JP; Kalthoff H; Rad R; Christiansen N; Bethan B; Kamlage B; Lerch MM; Mayerle J
    Gastroenterology; 2022 Nov; 163(5):1407-1422. PubMed ID: 35870514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review).
    Zuzčák M; Trnka J
    Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35730611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment.
    Wood LD; Canto MI; Jaffee EM; Simeone DM
    Gastroenterology; 2022 Aug; 163(2):386-402.e1. PubMed ID: 35398344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer.
    Nava GM; Madrigal Perez LA
    Expert Rev Mol Diagn; 2022 Apr; 22(4):439-447. PubMed ID: 35395916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative analysis of metabolome and gut microbiota in Patients with pancreatic ductal adenocarcinoma.
    Guo X; Hu Z; Rong S; Xie G; Nie G; Liu X; Jin G
    J Cancer; 2022; 13(5):1555-1564. PubMed ID: 35371330
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.